title: [Role of immediate reduction mammaplasty and mammapexy in the conservative treatment of breast cancers].
abstract: For some years, breast cancer surgery has become increasingly conservative, in order to preserve the aesthetic aspect of the treated breast and global harmony of the bosom. Unfortunately, conservative treatment is followed by 20% to 30% of unsatisfactory cosmetic results. Some studies have defined the various factors associated with an increased failure rate in terms of cosmetic results. These are related to the surgical technique, patient characteristics, or tumor specificities. In these cases with a poor aesthetic prognosis, the authors propose, following the initial tumorectomy, esther breast reduction or mammaexy, in order to reshape the volume of the breast as symmetrically as possible. In a series of 21 female patients operated at the Institut Gustave-Roussy between 1988 and 1991, the authors describe the aesthetic and carcinologic advantages of this method, and define its main indications. Although the aesthetic aspect of the operated breast was considered tube excellent in 33% of cases and good in 67% of cases, the global harmony of the breasts was excellent or good in 76% of cases. The 24 moderate or poor results were due to asymmetry of shape or volume, which is easy to improve by a secondary contralateral breast reduction.
authors.affiliation: Département de chirurgie générale et carcinologique, IGR, Institut Gustave-Roussy, Villejuif.
authors.forename: A
authors.initials: A
authors.lastname: Laxenaire
authors.forename: L
authors.initials: L
authors.lastname: Barreau-Pouhaer
authors.forename: R
authors.initials: R
authors.lastname: Arriagada
authors.forename: J Y
authors.initials: JY
authors.lastname: Petit
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000601:surgery*; D004954:Esthetics; D005260:Female; D006801:Humans; D016462:Mammaplasty / Q000379:methods* / Q000523:psychology; D008875:Middle Aged
vernacular_title: Place des réductions et pexies mammaires immédiates dans le traitement conservateur des cancers du sein.